The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of FOLFIRINOX (FFX) and gemcitabine+nab-paclitaxel (GnP) in initially unresectable locally advanced pancreatic cancer (uLAPC): A population-based study.
 
Kelvin K. Chan
No Relationships to Disclose
 
Helen Guo
No Relationships to Disclose
 
Jaclyn Marie Beca
No Relationships to Disclose
 
Ruby Redmond-Misner
No Relationships to Disclose
 
Wanrudee Isaranuwatchai
No Relationships to Disclose
 
Lucy Qiao
No Relationships to Disclose
 
Craig Earle
Consulting or Advisory Role - UnitedHealthcare
Patents, Royalties, Other Intellectual Property - UpToDate
 
Scott R. Berry
Consulting or Advisory Role - Celgene
 
James Joseph Biagi
No Relationships to Disclose
 
Stephen Welch
Honoraria - Amgen; Celgene; Roche; Sanofi
Consulting or Advisory Role - Amgen; Roche
Research Funding - Amgen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Roche
 
Brandon Meyers
Consulting or Advisory Role - Celgene
 
Nicole Mittmann
No Relationships to Disclose
 
Natalie Coburn
No Relationships to Disclose
 
Aliya Pardhan
No Relationships to Disclose
 
Jessica Arias
No Relationships to Disclose
 
Scott Gavura
No Relationships to Disclose
 
Erin Diane Kennedy
No Relationships to Disclose